Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study-Reference-Cited by-同舟云学术

Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study

Published:2017-06 Issue: Volume:188 Page:73-81
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Baber Usman,Sartori Samantha,Aquino Melissa,Kini Annapoorna,Kapadia Samir,Weiss Sandra,Strauss Craig,Muhlestein J. Brent,Toma Catalin,Rao Sunil V.,DeFranco Anthony,Poddar Kanhaiya L.,Chandrasekhar Jaya,Weintraub William,Henry Timothy D.,Bansilal Sameer,Baker Brian A.,Marrett Elizabeth,Keller Stuart,Effron Mark,Pocock Stuart,Mehran Roxana^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. 2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)

2. Cytochrome p-450 polymorphisms and response to clopidogrel;Mega;N Engl J Med,2009

3. Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis;Mega;JAMA,2010

4. Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis;Mega;Lancet,2010

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Impact of CYP2C19 Genotypes on Long‐Term Clinical Outcomes in Older Patients After Percutaneous Coronary Intervention;Journal of the American Heart Association;2024-05-21

2. Abbreviated or Standard Dual Antiplatelet Therapy by Sex in Patients at High Bleeding Risk;JAMA Cardiology;2024-01-01

3. Balancing Benefits and Risks of Oral Antiplatelet Strategies in patients With Coronary Artery Diseases: An Evolving Issue;Current Problems in Cardiology;2023-12

4. Comparative Risk of Hospitalized Bleeding of P2Y12 Inhibitors for Secondary Prophylaxis in Acute Coronary Syndrome After Percutaneous Coronary Intervention;Clinical Pharmacology & Therapeutics;2022-12-28

5. Dual Antiplatelet Therapy;Atrial Fibrillation - Diagnosis and Management in the 21st Century;2022-11-30